← Leaderboards
Pawel Dobrzanski
Oncoarendi Therapeutics, Llc
$237,200
Attributed
$237,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$237,200 · 1
By mechanism
R43$237,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Oncoarendi Therapeutics, Llc
Same institution · by research overlap
- Stanislaw Pikul$112,500
- Adam Golebiowski$1,060,293
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAgedAnimal ModelAreaBerylliumBiological AvailabilityBiological ProductsBleomycinBloodBronchoalveolar Lavage FluidCause Of DeathCd4 Lymphocyte CountCellsChitinaseChronicChronic BerylliosisChronic DiseaseClinical DevelopmentCollaborationsColoradoControl AnimalDeath RateDiagnosisAdrenal Cortex Hormones